Gastrointestinal Tolerability of Once-Daily Oral Semaglutide 25 mg in Adults with Overweight or Obesity, and the Relationship with Weight Loss: A Post Hoc Analysis of the OASIS 4 Trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.